Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Livzon Pharmaceutical Group ( (HK:1513) ) just unveiled an announcement.
Livzon Pharmaceutical Group Inc. has announced that its board of directors will meet on August 20, 2025, to review and approve the unaudited interim results for the first half of the year. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and strategic direction for the upcoming period.
The most recent analyst rating on (HK:1513) stock is a Hold with a HK$30.00 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. is a company operating in the pharmaceutical industry, focusing on the development and production of medical products and services. The company is involved in the healthcare market, providing various pharmaceutical solutions.
YTD Price Performance: 41.29%
Average Trading Volume: 2,234,504
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$38.97B
Learn more about 1513 stock on TipRanks’ Stock Analysis page.